Weston Blakeslee, Ph.D.
Chief Clinical Officer
Wes provides strategic leadership for RxRevu’s clinical team. He is responsible for developing the clinical strategy for the SwiftRx® product suite and co-leading the innovation arm of the company. Wes also is the co-lead for the ONC’s FHIR At Scale Task Force (FAST) Pilots Tiger Team, focused on improving national interoperability.
Wes brings seven years of research experience in a wide array of topics, including salmonella pathogenesis, human arterial aging, protein biochemistry, cancer stem cells, clinical trial design and cardiovascular pharmacology. He has secured approximately $1 million in non-dilutive funding to pursue innovative clinical decision support projects focused on antimicrobial stewardship, heart failure, behavioral health/PGx and general pediatrics.
Wes earned his Ph.D. in pharmacology from the University of Colorado-Anschutz Medical Campus. In his spare time, he enjoys playing tennis, snowboarding and spending quality time with his family and friends.
Reach out today to learn how you can be a part of RxRevu's growing partner network.